Arterial thrombosis is a major and global cause of human death and disability. Considering
the socioeconomic costs of arterial thrombosis, identification of biomarkers to predict and …

Venous thromboembolism (VTE) is a leading cause of morbidity and mortality worldwide (1).
The most common complications of the disease are thrombotic recurrence, post-thrombotic …

The Calibrated Automated Thrombogram (CAT), a plate-based assay that measures
thrombin generation and inhibition in plasma samples, is modified to measure the …

Antiphospholipid antibodies (aPL), particularly those directed against β 2-glycoprotein I,
cause activation of vascular cells (endothelial cells, platelets, monocytes) and release of …

Background Plasma contains cell‐derived extracellular vesicles (EVs), which participate in
physiopathological processes and have potential applications as disease biomarker …

Essentials• PSGL‐1+ microvesicles (MVs) may be important in venous thromboembolism
(VTE).• We measured plasma levels and parental origin of PSGL‐1+ MVs in patients with …

In our study entitled “Significant decrease in plasma D‐dimer levels and mean platelet
volume after a 3‐month treatment with rosuvastatin in patients with venous …

There is unequivocal scientific evidence that lipid and lipoprotein disorders play a pivotal
role in genesis, progression and complication of arterial thrombosis [1]. However, a causal …

Platelet-derived extracellular vesicles (PDEVs) are the most abundant amongst all types of
EVs in the circulation. However, the mechanisms leading to PDEVs release, their role in …

In this issue, Bucciarelli and colleagues [1] determine if microparticles (MPs) are an
independent risk factor for unprovoked venous thromboembolism (VTE) in a case-control …